These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Prostate cancer and apoptosis]. Mayora A; Arvelo F Invest Clin; 2011 Dec; 52(4):376-96. PubMed ID: 22523847 [TBL] [Abstract][Full Text] [Related]
12. Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient. Yoshida T; Kinoshita H; Segawa T; Nakamura E; Inoue T; Shimizu Y; Kamoto T; Ogawa O Cancer Res; 2005 Nov; 65(21):9611-6. PubMed ID: 16266977 [TBL] [Abstract][Full Text] [Related]
13. Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer. Armstrong AJ; George DJ Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):108-16. PubMed ID: 20066005 [TBL] [Abstract][Full Text] [Related]
14. Androgen receptor mutations in prostate cancer. Marcelli M; Ittmann M; Mariani S; Sutherland R; Nigam R; Murthy L; Zhao Y; DiConcini D; Puxeddu E; Esen A; Eastham J; Weigel NL; Lamb DJ Cancer Res; 2000 Feb; 60(4):944-9. PubMed ID: 10706109 [TBL] [Abstract][Full Text] [Related]
16. Androgen receptor mutations are associated with Gleason score in localized prostate cancer. Sanchez D; Rosell D; Honorato B; Lopez J; Arocena J; Sanz G BJU Int; 2006 Dec; 98(6):1320-5. PubMed ID: 17034507 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of prostate cancer progression to androgen independence. McPhaul MJ Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):373-88. PubMed ID: 18471793 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms leading to the development of hormone-resistant prostate cancer. Kasper S; Cookson MS Urol Clin North Am; 2006 May; 33(2):201-10, vii. PubMed ID: 16631458 [TBL] [Abstract][Full Text] [Related]